Arylamine-DNA adduct conformation in relation to mutagenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 376, Issue 1-2, 1997, Pages 13-19

  Beland, Frederick A ^a   Melchior Jr , William B ^a   Mourato, Luísa L G ^b   Santos, M Amélia ^b   Marques, M Matilde ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Arylamine; Conformation; DNA adduct; Ethylaniline; Methylaniline; Mutogenesis; N Acyloxy arylamine; N Hydroxy arylamine; Nuclear magnetic resonance

Indexed keywords

ANILINE DERIVATIVE; AROMATIC AMINE; TOBACCO SMOKE;

ARTICLE; DNA ADDUCT; MUTAGENESIS; MUTAGENICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

2-ACETYLAMINOFLUORENE; AMINOBIPHENYL COMPOUNDS; ANILINE COMPOUNDS; DEOXYGUANOSINE; DNA ADDUCTS; MAGNETIC RESONANCE SPECTROSCOPY; MUTAGENESIS; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES;

NICOTIANA TABACUM;

EID: 0030949281     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00020-1     Document Type: Article

References (36)

1. Beland, F.A., D.T. Beranek, K.L. Dooley, R.H. Heflich and F.F. Kadlubar (1983) Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis, Environ. Health Perspect., 49, 125-134.
2. Beland, F.A. and M.C. Poirier (1989) DNA adducts and carcinogenesis, in: A.E. Sirica (Ed.), The Pathobiology of Neoplasia, Plenum Publishing Corp., New York, pp. 57-80.
3. Cho, B.P., F.A. Beland and M.M. Marques (1992) NMR structural studies of a 15-mer DNA sequence from a ras protooncogene, modified at the first base of codon 61 with the carcinogen 4-aminobiphenyl, Biochemistry, 31, 9587-9602.
4. Cho, B.P., F.A. Beland and M.M. Marques (1994) NMR structural studies of a 15-mer DNA duplex from a ras protooncogene modified with the carcinogen 2-aminofluorene: conformational heterogeneity, Biochemistry, 33, 1373-1384.
5. Djurić, Z., R.H. Heflich, E.K. Fifer and F.A. Beland (1986) Metabolic activation of mutagenic and tumorigenic dinitropyrenes, in: C. Harris (Ed.), Biochemical and Molecular Epidemiology of Cancer, Alan, R. Liss, New York, pp. 441-447.
6. Eckel, L.M. and T.R. Krugh (1994a) 2-Aminofluorene modified DNA duplex exists in two interchangeable conformations, Nature: Struct. Biol., 1, 89-94.
7. Eckel, L.M. and T.R. Krugh (1994b) Structural characterization of two interchangeable conformations of a 2-aminofluorene-modified DNA oligomer by NMR and energy minimization, Biochemistry, 33, 13611-13624.
8. El-Bayoumy, K., E.J. LaVoie, L. Tulley-Freiler and S.S. Hecht (1981) Effects of ortho-methyl substituents on the mutagenicity of aminobiphenyls and aminonaphthalenes, Mutation Res., 90, 345-354.
9. Evans, F.E., D.W. Miller and F.A. Beland (1980) Sensitivity of the conformation of deoxyguanosine to binding at the C-8 position by N-acetylated and unacetylated 2-aminofluorene, Carcinogenesis, 1, 955-959.
10. Evans, F.E., D.W. Miller and R.A. Levine (1984) Conformation and dynamics of the 8-substituted deoxyguanosine 5′-monophosphate adduct of the carcinogen 2-(acetylamino)fluorene, J. Am. Chem. Soc., 106, 396-401.
11. Heflich, R.H., E.K. Fifer, Z. Djurić and F.A. Beland (1985a) DNA adduct formation and mutation induction by nitropyrenes in Salmonella and Chinese hamster ovary cells: relationships with nitroreduction and acetylation, Environ. Health Perspect., 62, 135-143.
12. Heflich, R.H., P.C. Howard and F.A. Beland (1985b) 1-Nitrosopyrene: an intermediate in the metabolic activation of 1-nitropyrene to a mutagen in Salmonella typhimurium TA1538, Mutation Res., 149, 25-32.
13. Hingerty, B.E. and S. Broyde (1986) Energy minimized structures of carcinogen-DNA adducts: 2-acetylaminofluorene and 2-aminofluorene, J. Biomol. Struct. Dyn., 4, 365-372.
14. Hoffmann, D. and S.S. Hecht (1990) Advances in tobacco carcinogenesis, in: C.S. Cooper and P.L. Grover (Eds.), Handbook of Experimental Pharmacology. Carcinogenesis and Mutagenesis, Vol. 94/I, Springer-Verlag, Heidelberg, pp. 63-102.
15. Howard, P.C., R.H. Heflich, F.E. Evans and F.A. Beland (1983) Formation of DNA adducts in vitro and in Salmonella typhimurium upon metabolic reduction of the environmental mutagen 1-nitropyrene, Cancer Res., 43, 2052-2058.
16. Jordan, F. and H. Niv (1977) C8-Amino purine nucleosides. A well-defined steric determinant of glycosyl conformational preferences, Biochim. Biophys. Acta, 476, 265-271.
17. Luceri, F., G. Pieraccini, G. Moneti and P. Dolara (1993) Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air, Toxicol. Ind. Health, 9, 405-413.
18. 1 mice and CD-1 mice, J. Toxicol. Environ. Health, 47, 195-208.
19. Marques, M.M., L.L.G. Mourato, M.A. Santos and F.A. Beland (1996) Synthesis, characterization, and conformational analysis of DNA adducts from methylated anilines present in tobacco smoke, Chem. Res. Toxicol., 9, 99-108.
20. Maron, D.M. and B.N. Ames (1983) Revised methods for the Salmonella mutagenicity test, Mutation Res., 113, 173-215.
21. Melchior, W.B., Jr., M.M. Marques and F.A. Beland (1994) Mutations induced by aromatic amine DNA adducts in pBR322, Carcinogenesis, 15, 889-899.
22. Mommsen, S. and J. Aagaard (1983) Tobacco as a risk factor in bladder cancer, Carcinogenesis, 4, 335-338.
23. Nohmi, T., K. Yoshikawa, M. Nakadate, R. Miyata and M. Ishidate, Jr. (1984) Mutations in Salmonella typhimurium and inactivation of Bacillus subtilis transforming DNA induced by phenylhydroxylamine derivatives, Mutation Res., 136, 159-168.
24. Nolan, S.J., R.R. Vyas, B.E. Hingerty, S. Ellis, S. Broyde, R. Shapiro and A.K. Basu (1996) Solution properties and computational analysis of an oligodeoxynucleotide containing N-(deoxyguanosin-8-yl)-1-aminopyrene, Carcinogenesis, 17, 133-144.
25. Nussbaum, M., E.S. Fiala, B. Kulkarni, K. El-Bayoumy and J.H. Weisburger (1983) In vivo metabolism of 3,2′-dimethyl-4-aminobiphenyl (DMAB) bearing on its organotropism in the Syrian golden hamster and the F344 rat, Environ. Health Perspect., 49, 223-231.
26. O'Handley, S.F., D.G. Sanford, R. Xu, C.C. Lester, B.E. Hingerty, S. Broyde and T.R. Krugh (1993) Structural characterization of an N-acetyl-2-aminofluorene (AAF) modified DNA oligomer by NMR, energy minimization, and molecular dynamics, Biochemistry, 32, 2481-2497.
27. Patrianakos, C. and D. Hoffmann (1979) Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke, J. Anal. Toxicol., 3, 150-154.
28. Poirier, M.C., N.F. Fullerton, T. Kinouchi, B.A. Smith and F.A. Beland (1991) Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene, Carcinogenesis, 12, 895-900.
29. Poirier, M.C., N.F. Fullerton, B.A. Smith and F.A. Beland (1995) DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels, Carcinogenesis, 16, 2917-2921.
30. Sabbioni, G. (1992) Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation, Chem.-Biol. Interactions, 81, 91-117.
31. Shapiro, R., B.E. Hingerty and S. Broyde (1989) Minor-groove binding models for acetylaminofluorene modified DNA, J. Biomol. Struct. Dyn., 7, 493-513.
32. Shapiro, R., D. Sidawi, Y.-S. Miao, B.E. Hingerty, K.E. Schmidt, J. Moskowitz and S. Broyde (1994) Conformation of amine-modified DNA: 2-aminofluorene- and 2-(acetylamino)fluorene-modified deoxydinucleoside monophosphates with all possible nearest neighbors. A comparison of search and optimization methods, Chem. Res. Toxicol., 7, 239-253.
33. Stolarski, R., L. Dudycz and D. Shugar (1980) NMR studies of the syn-anti dynamic equilibrium in purine nucleosides and nucleotides, Eur. J. Biochem., 108, 111-121.
34. Stolarski, R., C.-E. Hagberg and D. Shugar (1984) Studies on the dynamic syn-anti equilibrium in purine nucleosides and nucleotides with the aid of H and C NMR spectroscopy, Eur. J. Biochem., 138, 187-192.
35. Vineis, P. (1992) Epidemiological models of carcinogenesis: the example of bladder cancer, Cancer Epidemiol. Biomarkers Prev., 1, 149-153.
36. 1 mouse, Proc. Natl. Acad. Sci. USA, 83, 5825-5829.